Literature DB >> 24307619

The Val158Met polymorphism in the COMT gene is associated with increased cancer risks in Chinese population.

Can Tian1, Liping Liu, Xiaohong Yang, Hui Wu, Quchang Ouyang.   

Abstract

The Val158Met polymorphism in the COMT gene may affect the DNA repair pathways and be associated with the risk of cancer in Chinese population. However, the results of previous studies are inconsistent. The objective of this study was to investigate the association between the Val158Met polymorphism in the COMT gene and the risk of cancer for Chinese population by meta-analysis. We searched PubMed, Embase, CNKI, Weipu, and Wanfang databases, and the last search was updated on Sep. 26, 2013. Statistical analysis was performed using the Revman4.2 and Stata10.0 software. A total of 18 case-control studies concerning 5034 case and 6234 controls were included. In the total analysis, the results suggested a significant association between the Val158Met polymorphism in the COMT gene and the cancer risk in Chinese population: OR = 1.34, 95%CI = 1.04-1.73, and P = 0.03 for AA vs. AG + GG; OR = 1.39, 95%CI = 1.06-1.82, and P = 0.02; OR = 1.13, 95%CI = 1.01-1.27, and P = 0.04. In the subgroup analysis by cancer types, significant association was found in the breast cancer and esophageal squamous cell carcinoma. The current meta-analysis confirmed that the Val158Met polymorphism in the COMT gene may be a risk factor for cancer in Chinese population. In the future, more case-control studies are needed to validate our results.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24307619     DOI: 10.1007/s13277-013-1387-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  17 in total

1.  Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk.

Authors:  S-C Lin; Y-C Chou; M-H Wu; C-C Wu; W-Y Lin; C-P Yu; J-C Yu; S-L You; C-J Chen; C-A Sun
Journal:  Eur J Cancer Prev       Date:  2005-06       Impact factor: 2.497

2.  Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.

Authors:  Wanqing Wen; Qiuyin Cai; Xiao-Ou Shu; Jia-Rong Cheng; Fritz Parl; Larry Pierce; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

3.  Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.

Authors:  Qiong Wang; Hui Li; Ping Tao; Yuan-Ping Wang; Ping Yuan; Chun-Xia Yang; Jia-Yuan Li; Fei Yang; Hui Lee; Yuan Huang
Journal:  DNA Cell Biol       Date:  2011-03-27       Impact factor: 3.311

4.  Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.

Authors:  Yongjun Zhang; Shi Hua; Aiqin Zhang; Xiangming Kong; Chuming Jiang; Dehou Deng; Bao Wenlong
Journal:  Clin Lung Cancer       Date:  2012-06-01       Impact factor: 4.785

5.  Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.

Authors:  Ting-Chih Cheng; Shou-Tung Chen; Chiun-Sheng Huang; Yi-Ping Fu; Jyh-Cherng Yu; Chun-Wen Cheng; Pei-Ei Wu; Chen-Yang Shen
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

6.  [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women].

Authors:  Wen Tan; Jun Qi; De-Yin Xing; Xiao-Ping Miao; Kai-Feng Pan; Lian Zhang; Dong-Xin Lin
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2003-09

7.  Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females.

Authors:  Pen-Hui Yin; Hsin-Chen Lee; Gar-Yang Chau; Tsung-Yun Liu; Hsiu-Chih Liu; Wing-Yiu Lui; Chin-Wen Chi
Journal:  Cancer Lett       Date:  2004-08-30       Impact factor: 8.679

8.  Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia.

Authors:  A R Sanders; I Rusu; J Duan; J E Vander Molen; C Hou; S G Schwab; D B Wildenauer; M Martinez; P V Gejman
Journal:  Mol Psychiatry       Date:  2005-04       Impact factor: 15.992

9.  Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.

Authors:  Xiaoyan Yuan; Gangqiao Zhou; Yun Zhai; Weimin Xie; Ying Cui; Jia Cao; Lianteng Zhi; Hongxing Zhang; Hao Yang; Xiaoai Zhang; Wei Qiu; Yong Peng; Xiumei Zhang; Ling Yu; Xia Xia; Fuchu He
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

10.  Tea intake, COMT genotype, and breast cancer in Asian-American women.

Authors:  Anna H Wu; Chiu-Chen Tseng; David Van Den Berg; Mimi C Yu
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

View more
  3 in total

1.  Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case-control studies.

Authors:  Quan Zhou; Yan Wang; Aihua Chen; Yaling Tao; Huamei Song; Wei Li; Jing Tao; Manzhen Zuo
Journal:  Onco Targets Ther       Date:  2015-10-05       Impact factor: 4.147

2.  Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator.

Authors:  Theresa Swift-Scanlan; Christopher T Smith; Sabrina A Bardowell; Charlotte A Boettiger
Journal:  BMC Med Genomics       Date:  2014-01-24       Impact factor: 3.063

3.  Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome.

Authors:  K T Hall; J Kossowsky; T F Oberlander; T J Kaptchuk; J P Saul; V B Wyller; E Fagermoen; D Sulheim; J Gjerstad; A Winger; K J Mukamal
Journal:  Pharmacogenomics J       Date:  2016-07-26       Impact factor: 3.550

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.